Organoid Models to Study Human Infectious Diseases

Abstract

Infectious diseases have become significant events that threaten global public health and economic development. Since the 20th century, multiple outbreaks of infectious diseases have gradually deepened humanity's understanding of viral infections, prevention and treatment. Organoids possess a high degree of similarity to human physiological states and have strong self-organising capabilities. Research on infectious diseases based on organoids offers significant advantages in terms of availability, editability and diversity. In this perspective, we briefly introduce the development of organoids, focusing on historically significant infectious diseases that have caused fatal harm to human health, such as HIV, ZIKV, SARS-CoV-2 and MPXV. We further summarise relevant research on the pathogenic mechanisms of these viruses based on organoid models, host reactivity, and therapeutic strategies. Finally, we list the latest research techniques combined with organoid models, discuss the challenges faced in the development of organoids and look forward to the future prospects of organoids in vaccine and drug development.

Keywords

drug screening / infectious disease / organoids / virus

References

[1] H. V. Wilson, “A New Method by Which Sponges May be Artificially Reared,” Science 25 (1907): 912–915, https://doi.org/10.1126/science.25.649.912.

[2] P. Weiss and A. C. Taylor, “Reconstitution of Complete Organs From Single-Cell Suspensions of Chick Embryos in Advanced Stages of Differentiation,” Proceedings of the National Academy of Sciences of the United States of America 46 (1960): 1177–1185, https://doi.org/10.1073/pnas.46.9.1177.

[3] H. Clevers, “Modeling Development and Disease With Organoids,” Cell 165 (2016): 1586–1597, https://doi.org/10.1016/j.cell.2016.05.082.

[4] M. J. Evans and M. H. Kaufman, “Establishment in Culture of Pluripotential Cells From Mouse Embryos,” Nature 292 (1981): 154–156, https://doi.org/10.1038/292154a0.

[5] J. A. Thomson, J. Itskovitz-Eldor, S. S. Shapiro, et al., “Embryonic Stem Cell Lines Derived From Human Blastocysts,” Science 282 (1998): 1145–1147, https://doi.org/10.1126/science.282.5391.1145.

[6] K. Takahashi and S. Yamanaka, “Induction of Pluripotent Stem Cells From Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors,” Cell 126 (2006): 663–676, https://doi.org/10.1016/j.cell.2006.07.024.

[7] M. Eiraku, K. Watanabe, M. Matsuo-Takasaki, et al., “Self-Organized Formation of Polarized Cortical Tissues From ESCs and Its Active Manipulation by Extrinsic Signals,” Cell Stem Cell 3 (2008): 519–532, https://doi.org/10.1016/j.stem.2008.09.002.

[8] T. Sato, R. G. Vries, H. J. Snippert, et al., “Single Lgr5 Stem Cells Build Crypt-Villus Structures In Vitro Without a Mesenchymal Niche,” Nature 459 (2009): 262–265, https://doi.org/10.1038/nature07935.

[9] N. Barker, M. Huch, P. Kujala, et al., “Lgr5(+ve) Stem Cells Drive Self-Renewal in the Stomach and Build Long-Lived Gastric Units In Vitro,” Cell Stem Cell 6 (2010): 25–36, https://doi.org/10.1016/j.stem.2009.11.013.

[10] M. Eiraku, N. Takata, H. Ishibashi, et al., “Self-Organizing Optic-Cup Morphogenesis in Three-Dimensional Culture,” Nature 472 (2011): 51–56, https://doi.org/10.1038/nature09941.

[11] M. A. Lancaster, M. Renner, C.-A. Martin, et al., “Cerebral Organoids Model Human Brain Development and Microcephaly,” Nature 501 (2013): 373–379, https://doi.org/10.1038/nature12517.

[12] A. Taguchi, Y. Kaku, T. Ohmori, et al., “Redefining the In Vivo Origin of Metanephric Nephron Progenitors Enables Generation of Complex Kidney Structures From Pluripotent Stem Cells,” Cell Stem Cell 14 (2014): 53–67, https://doi.org/10.1016/j.stem.2013.11.010.

[13] M. Huch, C. Dorrell, S. f boj, et al., “In Vitro Expansion of Single Lgr5+ Liver Stem Cells Induced by Wnt-Driven Regeneration,” Nature 494 (2013): 247–250, https://doi.org/10.1038/nature11826.

[14] M. Huch, P. Bonfanti, S. F. Boj, et al., “Unlimited In Vitro Expansion of Adult Bi-Potent Pancreas Progenitors Through the Lgr5/R-Spondin Axis,” EMBO Journal 32 (2013): 2708–2721, https://doi.org/10.1038/emboj.2013.204.

[15] W. R. Karthaus, P. J. Iaquinta, J. Drost, et al., “Identification of Multipotent Luminal Progenitor Cells in Human Prostate Organoid Cultures,” Cell 159 (2014): 163–175, https://doi.org/10.1016/j.cell.2014.08.017.

[16] C. W. Chua, M. Shibata, M. Lei, et al., “Single Luminal Epithelial Progenitors Can Generate Prostate Organoids in Culture,” Nature Cell Biology 16 (2014): 951–961, https://doi.org/10.1038/ncb3047.

[17] B. L. Hogan, C. E. Barkauskas, H. A. Chapman, et al., “Repair and Regeneration of the Respiratory System: Complexity, Plasticity, and Mechanisms of Lung Stem Cell Function,” Cell Stem Cell 15 (2014): 123–138, https://doi.org/10.1016/j.stem.2014.07.012.

[18] J. R. Linnemann, H. Miura, L. K. Meixner, et al., “Quantification of Regenerative Potential in Primary Human Mammary Epithelial Cells,” Development 142 (2015): 3239–3251, https://doi.org/10.1242/dev.123554.

[19] M. Kessler, K. Hoffmann, V. Brinkmann, et al., “The Notch and Wnt Pathways Regulate Stemness and Differentiation in Human Fallopian Tube Organoids,” Nature Communications 6 (2015): 8989, https://doi.org/10.1038/ncomms9989.

[20] M. Y. Turco, L. Gardner, R. G. Kay, et al., “Trophoblast Organoids as a Model for Maternal-Fetal Interactions During Human Placentation,” Nature 564 (2018): 263–267, https://doi.org/10.1038/s41586-018-0753-3.

[21] S. R. Finkbeiner, X.-L. Zeng, B. Utama, et al., “Stem Cell-Derived Human Intestinal Organoids as an Infection Model for Rotaviruses,” MBio 3 (2012): e00159-00112, https://doi.org/10.1128/mBio.00159-12.

[22] X. Qian, H. N. Nguyen, M. M. Song, et al., “Brain-Region-Specific Organoids Using Mini-Bioreactors for Modeling ZIKV Exposure,” Cell 165 (2016): 1238–1254, https://doi.org/10.1016/j.cell.2016.04.032.

[23] S. S. Mahalingam, S. Jayaraman, N. Bhaskaran, et al., “Polyamine Metabolism Impacts T Cell Dysfunction in the Oral Mucosa of People Living With HIV,” Nature Communications 14 (2023): 399, https://doi.org/10.1038/s41467-023-36163-2.

[24] P. Li, S. T. Pachis, G. Xu, et al., “Mpox Virus Infection and Drug Treatment Modelled in Human Skin Organoids,” Nature Microbiology 8 (2023): 2067–2079, https://doi.org/10.1038/s41564-023-01489-6.

[25] W. Kong, J. Frouard, G. Xie, et al., “Neuroinflammation Generated by HIV-Infected Microglia Promotes Dysfunction and Death of Neurons in Human Brain Organoids,” PNAS Nexus 3 (2024): pgae179, https://doi.org/10.1093/pnasnexus/pgae179.

[26] K. Whalley, “Techniques: Spinning Organoids Shed Light on Zika,” Nature Reviews. Neuroscience 17 (2016): 334–335, https://doi.org/10.1038/nrn.2016.66.

[27] Y. P. Xu, Y. Qiu, B. Zhang, et al., “Zika Virus Infection Induces RNAi-Mediated Antiviral Immunity in Human Neural Progenitors and Brain Organoids,” Cell Research 29 (2019): 265–273, https://doi.org/10.1038/s41422-019-0152-9.

[28] M. R. Shaker, A. Slonchak, B. al-mhanawi, et al., “Choroid Plexus Defects in Down Syndrome Brain Organoids Enhance Neurotropism of SARS-CoV-2,” Science Advances 10 (2024): eadj4735, https://doi.org/10.1126/sciadv.adj4735.

[29] Y. Hou, C. Li, C. Yoon, et al., “Enhanced Replication of SARS-CoV-2 Omicron BA.2 in Human Forebrain and Midbrain Organoids,” Signal Transduction and Targeted Therapy 7 (2022): 381, https://doi.org/10.1038/s41392-022-01241-2.

[30] V. Krenn, C. Bosone, T. R. Burkard, et al., “Organoid Modeling of Zika and Herpes Simplex Virus 1 Infections Reveals Virus-Specific Responses Leading to Microcephaly,” Cell Stem Cell 28 (2021): 1362–1379, https://doi.org/10.1016/j.stem.2021.03.004.

[31] C. T. Wu, P. V. Lidsky, Y. Xiao, et al., “SARS-CoV-2 Replication in Airway Epithelia Requires Motile Cilia and Microvillar Reprogramming,” Cell 186 (2023): 112–130, https://doi.org/10.1016/j.cell.2022.11.030.

[32] X. Zhang, S. J.-A. Lam, J. D. Ip, et al., “Characterizing Fitness and Immune Escape of SARS-CoV-2 EG.5 Sublineage Using Elderly Serum and Nasal Organoid,” iScience 27 (2024): 109706, https://doi.org/10.1016/j.isci.2024.109706.

[33] J. M. Kastenschmidt, S. Sureshchandra, A. Jain, et al., “Influenza Vaccine Format Mediates Distinct Cellular and Antibody Responses in Human Immune Organoids,” Immunity 56 (2023): 1910–1926, https://doi.org/10.1016/j.immuni.2023.06.019.

[34] J. Tanaka, H. Senpuku, M. Ogawa, et al., “Human Induced Pluripotent Stem Cell-Derived Salivary Gland Organoids Model SARS-CoV-2 Infection and Replication,” Nature Cell Biology 24 (2022): 1595–1605, https://doi.org/10.1038/s41556-022-01007-6.

[35] S. L. Leibel, R. N. McVicar, R. Murad, et al., “A Therapy for Suppressing Canonical and Noncanonical SARS-CoV-2 Viral Entry and an Intrinsic Intrapulmonary Inflammatory Response,” Proceedings of the National Academy of Sciences of the United States of America 121 (2024): e2408109121, https://doi.org/10.1073/pnas.2408109121.

[36] Y. Han, X. Duan, L. Yang, et al., “Identification of SARS-CoV-2 Inhibitors Using Lung and Colonic Organoids,” Nature 589 (2021): 270–275, https://doi.org/10.1038/s41586-020-2901-9.

[37] W. Wang, J. Yang, P. Kang, et al., “Direct Infection of SARS-CoV-2 in Human iPSC-Derived 3D Cardiac Organoids Recapitulates COVID-19 Myocarditis,” Virologica Sinica 38 (2023): 971–974, https://doi.org/10.1016/j.virs.2023.09.005.

[38] E. De Crignis, T. Hossain, S. Romal, et al., “Application of Human Liver Organoids as a Patient-Derived Primary Model for HBV Infection and Related Hepatocellular Carcinoma,” eLife 10 (2021): e60747, https://doi.org/10.7554/eLife.60747.

[39] J. Chen, L. Shen, Q. Guo, et al., “The Downregulation of Tapasin in Dendritic Cell Regulates CD8(+) T Cell Autophagy to Hamper Hepatitis B Viral Clearance in the Induced Pluripotent Stem Cell-Derived Hepatocyte Organoid,” Journal of Medical Virology 96 (2024): e29546, https://doi.org/10.1002/jmv.29546.

[40] Y. Baktash, A. Madhav, K. E. Coller, and G. Randall, “Single Particle Imaging of Polarized Hepatoma Organoids Upon Hepatitis C Virus Infection Reveals an Ordered and Sequential Entry Process,” Cell Host & Microbe 23 (2018): 382–394, https://doi.org/10.1016/j.chom.2018.02.005.

[41] P. Li, Y. Li, Y. Wang, et al., “Recapitulating Hepatitis E Virus-Host Interactions and Facilitating Antiviral Drug Discovery in Human Liver-Derived Organoids,” Science Advances 8 (2022): eabj5908, https://doi.org/10.1126/sciadv.abj5908.

[42] P. Li, Z. du, M. M. Lamers, et al., “Mpox Virus Infects and Injures Human Kidney Organoids, but Responding to Antiviral Treatment,” Cell Discovery 9 (2023): 34, https://doi.org/10.1038/s41421-023-00545-z.

[43] G. G. Giobbe, F. Bonfante, B. C. Jones, et al., “SARS-CoV-2 Infection and Replication in Human Gastric Organoids,” Nature Communications 12 (2021): 6610, https://doi.org/10.1038/s41467-021-26762-2.

[44] V. Monteil, H. Kwon, L. John, et al., “Identification of CCZ1 as an Essential Lysosomal Trafficking Regulator in Marburg and Ebola Virus Infections,” Nature Communications 14 (2023): 6785, https://doi.org/10.1038/s41467-023-42526-6.

[45] Y. Watanabe, I. Kimura, R. Hashimoto, et al., “Virological Characterization of the 2022 Outbreak-Causing Monkeypox Virus Using Human Keratinocytes and Colon Organoids,” Journal of Medical Virology 95 (2023): e28827, https://doi.org/10.1002/jmv.28827.

[46] B. V. Vijayalakshmi Ayyar, K. Ettayebi, W. Salmen, et al., “CLIC and Membrane Wound Repair Pathways Enable Pandemic Norovirus Entry and Infection,” Nature Communications 14 (2023): 1148, https://doi.org/10.1038/s41467-023-36398-z.

[47] T. Kawagishi, L. Sánchez-Tacuba, N. Feng, et al., “Mucosal and Systemic Neutralizing Antibodies to Norovirus Induced in Infant Mice Orally Inoculated With Recombinant Rotaviruses,” Proceedings of the National Academy of Sciences of the United States of America 120 (2023): e2214421120, https://doi.org/10.1073/pnas.2214421120.

[48] L. Yang, Y. Han, T. Zhang, et al., “Human Vascularized Macrophage-Islet Organoids to Model Immune-Mediated Pancreatic β Cell Pyroptosis Upon Viral Infection,” Cell Stem Cell 31 (2024): 1612–1629, https://doi.org/10.1016/j.stem.2024.08.007.

[49] W. Yang, C. Zhang, Y. H. Wu, et al., “Mice 3D Testicular Organoid System as a Novel Tool to Study Zika Virus Pathogenesis,” Virologica Sinica 38 (2023): 66–74, https://doi.org/10.1016/j.virs.2022.10.001.

[50] H. Wu, X. Y. Huang, M. X. Sun, et al., “Zika Virus Targets Human Trophoblast Stem Cells and Prevents Syncytialization in Placental Trophoblast Organoids,” Nature Communications 14 (2023): 5541, https://doi.org/10.1038/s41467-023-41158-0.

[51] S. Koster, R. K. Gurumurthy, N. Kumar, et al., “Modelling Chlamydia and HPV Co-Infection in Patient-Derived Ectocervix Organoids Reveals Distinct Cellular Reprogramming,” Nature Communications 13 (2022): 1030, https://doi.org/10.1038/s41467-022-28569-1.

[52] M. Mahy, K. Marsh, K. Sabin, et al., “HIV Estimates Through 2018: Data for Decision-Making,” AIDS 33, no. 3 (2019): S203–S211, https://doi.org/10.1097/qad.0000000000002321.

[53] H. Deng, R. Liu, W. Ellmeier, et al., “Identification of a Major Co-Receptor for Primary Isolates of HIV-1,” Nature 381 (1996): 661–666, https://doi.org/10.1038/381661a0.

[54] N. F. McMyn, J. Varriale, E. J. Fray, et al., “The Latent Reservoir of Inducible, Infectious HIV-1 Does Not Decrease Despite Decades of Antiretroviral Therapy,” Journal of Clinical Investigation 133 (2023): e171554, https://doi.org/10.1172/jci171554.

[55] R. S. Dos Reis, M. C. E. Wagner, S. McKenna, and V. Ayyavoo, “Neuroinflammation Driven by Human Immunodeficiency Virus-1 (HIV-1) Directs the Expression of Long Noncoding RNA RP11-677M14.2 Resulting in Dysregulation of Neurogranin In Vivo and In Vitro,” Journal of Neuroinflammation 21 (2024): 107, https://doi.org/10.1186/s12974-024-03102-x.

[56] W. Cao, E. Hsieh, and T. Li, “Optimizing Treatment for Adults With HIV/AIDS in China: Successes Over Two Decades and Remaining Challenges,” Current HIV/AIDS Reports 17 (2020): 26–34, https://doi.org/10.1007/s11904-019-00478-x.

[57] F. E. T. Foka and H. T. Mufhandu, “Current ARTs, Virologic Failure, and Implications for AIDS Management: A Systematic Review,” Viruses 15, no. 8 (2023): 1732, https://doi.org/10.3390/v15081732.

[58] M. G. Weber, C. J. Walters-Laird, A. Kol, et al., “Gut Germinal Center Regeneration and Enhanced Antiviral Immunity by Mesenchymal Stem/Stromal Cells in SIV Infection,” JCI Insight 6 (2021): e149033, https://doi.org/10.1172/jci.insight.149033.

[59] C. D. Caiaffa, G. Tukeman, C. Z. Delgado, et al., “Dolutegravir Induces FOLR1 Expression During Brain Organoid Development,” Frontiers in Molecular Neuroscience 17 (2024): 1394058, https://doi.org/10.3389/fnmol.2024.1394058.

[60] D. Vue and Q. Tang, “Zika Virus Overview: Transmission, Origin, Pathogenesis, Animal Model and Diagnosis,” Zoonoses (Burlingt) 1 (2021): 14, https://doi.org/10.15212/zoonoses-2021-0017.

[61] A. Agrelli, R. R. de Moura, S. Crovella, and L. A. C. Brandão, “ZIKA Virus Entry Mechanisms in Human Cells,” Infection, Genetics and Evolution 69 (2019): 22–29, https://doi.org/10.1016/j.meegid.2019.01.018.

[62] Y. Wu, Q. Liu, J. Zhou, et al., “Zika Virus Evades Interferon-Mediated Antiviral Response Through the Co-Operation of Multiple Nonstructural Proteins In Vitro,” Cell Discovery 3 (2017): 17006, https://doi.org/10.1038/celldisc.2017.6.

[63] X. Chen, Y. Yan, Z. Liu, et al., “In Vitro and In Vivo Inhibition of the Host TRPC4 Channel Attenuates Zika Virus Infection,” EMBO Molecular Medicine 16 (2024): 1817–1839, https://doi.org/10.1038/s44321-024-00103-4.

[64] T. Zhou, L. Tan, G. Y. Cederquist, et al., “High-Content Screening in hPSC-Neural Progenitors Identifies Drug Candidates That Inhibit Zika Virus Infection in Fetal-Like Organoids and Adult Brain,” Cell Stem Cell 21 (2017): 274–283, https://doi.org/10.1016/j.stem.2017.06.017.

[65] M. Hoffmann, H. Kleine-Weber, S. Schroeder, et al., “SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor,” Cell 181 (2020): 271–280, https://doi.org/10.1016/j.cell.2020.02.052.

[66] T. Ou, H. Mou, L. Zhang, A. Ojha, H. Choe, and M. Farzan, “Hydroxychloroquine-Mediated Inhibition of SARS-CoV-2 Entry Is Attenuated by TMPRSS2,” PLoS Pathogens 17 (2021): e1009212, https://doi.org/10.1371/journal.ppat.1009212.

[67] L. Cantuti-Castelvetri, R. Ojha, L. D. Pedro, et al., “Neuropilin-1 Facilitates SARS-CoV-2 Cell Entry and Infectivity,” Science 370 (2020): 856–860, https://doi.org/10.1126/science.abd2985.

[68] Y. R. Guo, Q. D. Cao, Z. S. Hong, et al., “The Origin, Transmission and Clinical Therapies on Coronavirus Disease 2019 (COVID-19) Outbreak - An Update on the Status,” Military Medical Research 7 (2020): 11, https://doi.org/10.1186/s40779-020-00240-0.

[69] X. Tang, D. Xue, T. Zhang, et al., “A Multi-Organoid Platform Identifies CIART as a Key Factor for SARS-CoV-2 Infection,” Nature Cell Biology 25 (2023): 381–389, https://doi.org/10.1038/s41556-023-01095-y.

[70] C. Li, J. Huang, Y. Yu, et al., “Human Airway and Nasal Organoids Reveal Escalating Replicative Fitness of SARS-CoV-2 Emerging Variants,” Proceedings of the National Academy of Sciences of the United States of America 120 (2023): e2300376120, https://doi.org/10.1073/pnas.2300376120.

[71] Y. Ma, Y. Zhou, D. Jiang, et al., “Integration of Human Organoids Single-Cell Transcriptomic Profiles and Human Genetics Repurposes Critical Cell Type-Specific Drug Targets for Severe COVID-19,” Cell Proliferation 57 (2024): e13558, https://doi.org/10.1111/cpr.13558.

[72] T. Ebisudani, S. Sugimoto, K. Haga, et al., “Direct Derivation of Human Alveolospheres for SARS-CoV-2 Infection Modeling and Drug Screening,” Cell Reports 35 (2021): 109218, https://doi.org/10.1016/j.celrep.2021.109218.

[73] T. M. Karpiński, M. Ożarowski, A. Seremak-Mrozikiewicz, H. Wolski, and D. Wlodkowic, “The 2020 Race Towards SARS-CoV-2 Specific Vaccines,” Theranostics 11 (2021): 1690–1702, https://doi.org/10.7150/thno.53691.

[74] J. Chen, P. Wang, L. Yuan, et al., “A Live Attenuated Virus-Based Intranasal COVID-19 Vaccine Provides Rapid, Prolonged, and Broad Protection Against SARS-CoV-2,” Science Bulletin (Beijing) 67 (2022): 1372–1387, https://doi.org/10.1016/j.scib.2022.05.018.

[75] H. Xu, G. Liu, J. Gong, et al., “Investigating and Resolving Cardiotoxicity Induced by COVID-19 Treatments Using Human Pluripotent Stem Cell-Derived Cardiomyocytes and Engineered Heart Tissues,” Advanced Science 9 (2022): e2203388, https://doi.org/10.1002/advs.202203388.

[76] J. Lu, H. Xing, C. Wang, et al., “Mpox (Formerly Monkeypox): Pathogenesis, Prevention, and Treatment,” Signal Transduction and Targeted Therapy 8 (2023): 458, https://doi.org/10.1038/s41392-023-01675-2.

[77] Á. O'Toole, R. A. Neher, N. Ndodo, et al., “APOBEC3 Deaminase Editing in Mpox Virus as Evidence for Sustained Human Transmission Since at Least 2016,” Science 382 (2023): 595–600, https://doi.org/10.1126/science.adg8116.

[78] M. Aid, M. Sciacca, K. McMahan, et al., “Mpox Infection Protects Against Re-Challenge in Rhesus Macaques,” Cell 186 (2023): 4652–4661, https://doi.org/10.1016/j.cell.2023.08.023.

[79] A. Nalca and E. E. Zumbrun, “ACAM2000: The New Smallpox Vaccine for United States Strategic National Stockpile,” Drug Design, Development and Therapy 4 (2010): 71–79, https://doi.org/10.2147/dddt.s3687.

[80] S. E. Frey, P. L. Winokur, H. Hill, J. B. Goll, P. Chaplin, and R. B. Belshe, “Phase II Randomized, Double-Blinded Comparison of a Single High Dose (5×10(8) TCID50) of Modified Vaccinia Ankara Compared to a Standard Dose (1×10(8) TCID50) in Healthy Vaccinia-naïve Individuals,” Vaccine 32 (2014): 2732–2739, https://doi.org/10.1016/j.vaccine.2014.02.043.

[81] F. Hou, Y. Zhang, X. Liu, et al., “mRNA Vaccines Encoding Fusion Proteins of Monkeypox Virus Antigens Protect Mice From Vaccinia Virus Challenge,” Nature Communications 14 (2023): 5925, https://doi.org/10.1038/s41467-023-41628-5.

[82] G. S. Cooke, B. Flower, E. Cunningham, et al., “Progress Towards Elimination of Viral Hepatitis: A Lancet Gastroenterology & Hepatology Commission Update,” Lancet Gastroenterology & Hepatology 9 (2024): 346–365, https://doi.org/10.1016/s2468-1253(23)00321-7.

[83] C. J. Zhang, S. R. Meyer, M. J. O'Meara, et al., “A Human Liver Organoid Screening Platform for DILI Risk Prediction,” Journal of Hepatology 78 (2023): 998–1006, https://doi.org/10.1016/j.jhep.2023.01.019.

[84] D. Cao, J. Y. Ge, Y. Wang, T. Oda, and Y. W. Zheng, “Hepatitis B Virus Infection Modeling Using Multi-Cellular Organoids Derived From Human Induced Pluripotent Stem Cells,” World Journal of Gastroenterology 27 (2021): 4784–4801, https://doi.org/10.3748/wjg.v27.i29.4784.

[85] M. Elbadawy, Y. Kato, N. Saito, et al., “Establishment of Intestinal Organoid From Rousettus Leschenaultii and the Susceptibility to Bat-Associated Viruses, SARS-CoV-2 and Pteropine Orthoreovirus,” International Journal of Molecular Sciences 22 (2021): 10763, https://doi.org/10.3390/ijms221910763.

[86] X. Liu, C. Li, Z. Wan, et al., “Analogous Comparison Unravels Heightened Antiviral Defense and Boosted Viral Infection Upon Immunosuppression in Bat Organoids,” Signal Transduction and Targeted Therapy 7 (2022): 392, https://doi.org/10.1038/s41392-022-01247-w.

[87] L. Liu, G. Chen, S. Huang, and F. Wen, “Receptor Binding Properties of Neuraminidase for Influenza A Virus: An Overview of Recent Research Advances,” Virulence 14 (2023): 2235459, https://doi.org/10.1080/21505594.2023.2235459.

[88] T. R. Mosmann, A. J. McMichael, A. LeVert, J. W. McCauley, and J. W. Almond, “Opportunities and Challenges for T Cell-Based Influenza Vaccines,” Nature Reviews. Immunology 24 (2024): 736–752, https://doi.org/10.1038/s41577-024-01030-8.

[89] S. M. Pires, C. L. Fischer-Walker, C. F. Lanata, et al., “Aetiology-Specific Estimates of the Global and Regional Incidence and Mortality of Diarrhoeal Diseases Commonly Transmitted Through Food,” PLoS One 10 (2015): e0142927, https://doi.org/10.1371/journal.pone.0142927.

[90] K. A. Gianopulos, T. Komala Sari, D. J. Weed, S. M. Pritchard, and A. V. Nicola, “Conformational Changes in Herpes Simplex Virus Glycoprotein C,” Journal of Virology 96 (2022): e0016322, https://doi.org/10.1128/jvi.00163-22.

[91] A. Rybak-Wolf, E. Wyler, T. M. Pentimalli, et al., “Modelling Viral Encephalitis Caused by Herpes Simplex Virus 1 Infection in Cerebral Organoids,” Nature Microbiology 8 (2023): 1252–1266, https://doi.org/10.1038/s41564-023-01405-y.

[92] H. Qiao, W. Zhao, M. Guo, et al., “Cerebral Organoids for Modeling of HSV-1-Induced-Amyloid β Associated Neuropathology and Phenotypic Rescue,” International Journal of Molecular Sciences 23 (2022): 5981, https://doi.org/10.3390/ijms23115981.

[93] L. D'Aiuto, J. K. Caldwell, C. T. Wallace, et al., “The Impaired Neurodevelopment of Human Neural Rosettes in HSV-1-Infected Early Brain Organoids,” Cells 11, no. 22 (2022): 3539, https://doi.org/10.3390/cells11223539.

[94] J. Y. Chang, C. Balch, and H. S. Oh, “Toward the Eradication of Herpes Simplex Virus: Vaccination and Beyond,” Viruses 16, no. 9 (2024): 1476, https://doi.org/10.3390/v16091476.

[95] M. Aubert, A. K. Haick, D. E. Strongin, et al., “Gene Editing for Latent Herpes Simplex Virus Infection Reduces Viral Load and Shedding In Vivo,” Nature Communications 15 (2024): 4018, https://doi.org/10.1038/s41467-024-47940-y.

[96] T. Crook, J. A. Tidy, and K. H. Vousden, “Degradation of p53 Can Be Targeted by HPV E6 Sequences Distinct From Those Required for p53 Binding and Trans-Activation,” Cell 67 (1991): 547–556, https://doi.org/10.1016/0092-8674(91)90529-8.

[97] K. Lõhmussaar, R. Oka, J. E. Valle-Inclan, et al., “Patient-Derived Organoids Model Cervical Tissue Dynamics and Viral Oncogenesis in Cervical Cancer,” Cell Stem Cell 28 (2021): 1380–1396, https://doi.org/10.1016/j.stem.2021.03.012.

[98] R. Wang, H. Huang, C. Yu, X. Li, Y. Wang, and L. Xie, “Current Status and Future Directions for the Development of Human Papillomavirus Vaccines,” Frontiers in Immunology 15 (2024): 1362770, https://doi.org/10.3389/fimmu.2024.1362770.

[99] Y. Han, L. Yang, L. A. Lacko, and S. Chen, “Human Organoid Models to Study SARS-CoV-2 Infection,” Nature Methods 19 (2022): 418–428, https://doi.org/10.1038/s41592-022-01453-y.

[100] A. G. Allen, C. H. Chung, S. D. Worrell, et al., “Assessment of Anti-HIV-1 Guide RNA Efficacy in Cells Containing the Viral Target Sequence, Corresponding gRNA, and CRISPR/Cas9,” Frontiers in Genome Editing 5 (2023): 1101483, https://doi.org/10.3389/fgeed.2023.1101483.

[101] T. R. Abbott, G. Dhamdhere, Y. Liu, et al., “Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza,” Cell 181 (2020): 865–876, https://doi.org/10.1016/j.cell.2020.04.020.

[102] H. Jian, X. Li, Q. Dong, S. Tian, and S. Bai, “In Vitro Construction of Liver Organoids With Biomimetic Lobule Structure by a Multicellular 3D Bioprinting Strategy,” Cell Proliferation 56 (2023): e13465, https://doi.org/10.1111/cpr.13465.

[103] S. Shrestha, M. G. Vanga, C. Jonnadula, et al., “Reproducible Generation of Human Liver Organoids (HLOs) on a Pillar Plate Platform via Microarray 3D Bioprinting,” Lab on a Chip 24 (2024): 2747–2761, https://doi.org/10.1039/d4lc00149d.

[104] H. Wang, T. Wen, W. Zhu, K. Li, X. Gong, and Z. Li, “Microfluidic Strategies for Biomimetic Lung Chip Establishment and SARS-CoV2 Study,” Materials Today Bio 24 (2024): 100905, https://doi.org/10.1016/j.mtbio.2023.100905.

[105] J. Berg, T. Hiller, M. S. Kissner, et al., “Optimization of Cell-Laden Bioinks for 3D Bioprinting and Efficient Infection With Influenza A Virus,” Scientific Reports 8 (2018): 13877, https://doi.org/10.1038/s41598-018-31880-x.

[106] M. A. Skylar-Scott, J. Y. Huang, A. Lu, et al., “Orthogonally Induced Differentiation of Stem Cells for the Programmatic Patterning of Vascularized Organoids and Bioprinted Tissues,” Nature Biomedical Engineering 6 (2022): 449–462, https://doi.org/10.1038/s41551-022-00856-8.

[107] R. Hashimoto, J. Takahashi, K. Shirakura, et al., “SARS-CoV-2 Disrupts Respiratory Vascular Barriers by Suppressing Claudin-5 Expression,” Science Advances 8 (2022): eabo6783, https://doi.org/10.1126/sciadv.abo6783.

[108] V. Natarajan, C. R. Simoneau, A. L. Erickson, et al., “Modelling T-Cell Immunity Against Hepatitis C Virus With Liver Organoids in a Microfluidic Coculture System,” Open Biology 12 (2022): 210320, https://doi.org/10.1098/rsob.210320.

[109] L. Si, H. Bai, M. Rodas, et al., “A Human-Airway-on-a-Chip for the Rapid Identification of Candidate Antiviral Therapeutics and Prophylactics,” Nature Biomedical Engineering 5 (2021): 815–829, https://doi.org/10.1038/s41551-021-00718-9.

[110] Y. Zhang, S. M. Lu, J. J. Zhuang, and L. G. Liang, “Advances in Gut-Brain Organ Chips,” Cell Proliferation 57, no. 9 (2024): e13724, https://doi.org/10.1111/cpr.13724.

[111] B. Gabbin, V. Meraviglia, M. L. Angenent, et al., “Heart and Kidney Organoids Maintain Organ-Specific Function in a Microfluidic System,” Materials Today Bio 23 (2023): 100818, https://doi.org/10.1016/j.mtbio.2023.100818.

[112] G. Xie, L. Zhu, S. Liu, et al., “Multi-Omics Analysis of Attenuated Variant Reveals Potential Evaluation Marker of Host Damaging for SARS-CoV-2 Variants,” Science China. Life Sciences 67 (2024): 83–95, https://doi.org/10.1007/s11427-022-2379-x.

[113] Y. Huang, V. Bergant, V. Grass, et al., “Multi-Omics Characterization of the Monkeypox Virus Infection,” Nature Communications 15 (2024): 6778, https://doi.org/10.1038/s41467-024-51074-6.

[114] M. Mukhopadhyay, “Organoids Get an Upgrade,” Nature Methods 21 (2024): 2228–2229, https://doi.org/10.1038/s41592-024-02549-3.

[115] K. Zhang, J. Xi, Y. Wang, et al., “A Microfluidic Chip-Based Automated System for Whole-Course Monitoring the Drug Responses of Organoids,” Analytical Chemistry 96 (2024): 10092–10101, https://doi.org/10.1021/acs.analchem.4c02075.

[116] A. Nathan, E. J. Rossin, C. Kaseke, et al., “Structure-Guided T Cell Vaccine Design for SARS-CoV-2 Variants and Sarbecoviruses,” Cell 184 (2021): 4401–4413, https://doi.org/10.1016/j.cell.2021.06.029.

[117] L. E. Wagar, A. Salahudeen, C. M. Constantz, et al., “Modeling Human Adaptive Immune Responses With Tonsil Organoids,” Nature Medicine 27 (2021): 125–135, https://doi.org/10.1038/s41591-020-01145-0.

[118] J. W. Rumsey, C. Lorance, M. Jackson, et al., “Classical Complement Pathway Inhibition in a ‘Human-on-a-Chip’ Model of Autoimmune Demyelinating Neuropathies,” Advanced Therapeutics 5 (2022): 2200030, https://doi.org/10.1002/adtp.202200030.

[119] B. Schuster, M. Junkin, S. S. Kashaf, et al., “Automated Microfluidic Platform for Dynamic and Combinatorial Drug Screening of Tumor Organoids,” Nature Communications 11 (2020): 5271, https://doi.org/10.1038/s41467-020-19058-4.

[120] F. Yin, X. Zhang, L. Wang, et al., “HiPSC-Derived Multi-Organoids-on-Chip System for Safety Assessment of Antidepressant Drugs,” Lab on a Chip 21 (2021): 571–581, https://doi.org/10.1039/d0lc00921k.

RIGHTS & PERMISSIONS

2025 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.